SLU-PP-332 is a synthetic compound recognized as a potent, non-selective agonist of estrogen-related receptors (ERRs), particularly ERRα, with an effective concentration (EC₅₀) of 98 nM. This compound has shown promise in counteracting metabolic syndrome in mice, indicating its potential as a treatment for obesity and related metabolic disorders.
read more..